THYRO-BLOCK Drug Patent Profile
✉ Email this page to a colleague
When do Thyro-block patents expire, and what generic alternatives are available?
Thyro-block is a drug marketed by Meda Pharms and is included in one NDA.
The generic ingredient in THYRO-BLOCK is potassium iodide. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thyro-block
A generic version of THYRO-BLOCK was approved as potassium iodide by MISSION PHARMACAL on March 24th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for THYRO-BLOCK?
- What are the global sales for THYRO-BLOCK?
- What is Average Wholesale Price for THYRO-BLOCK?
Summary for THYRO-BLOCK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 211 |
| Patent Applications: | 3,897 |
| DailyMed Link: | THYRO-BLOCK at DailyMed |
US Patents and Regulatory Information for THYRO-BLOCK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meda Pharms | THYRO-BLOCK | potassium iodide | TABLET;ORAL | 018307-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
